{
  "question_stem": {
    "en": "A randomized controlled study investigated the effects of single-dose dexmedetomidine on emergence delirium (ED) in children who were under anesthesia induced with sevoflurane. A total of 2,500 patients age 2-7 who were scheduled for tonsillectomy were enrolled in the study; 80% were randomized to receive dexmedetomidine 0.5 mcg/kg or volume-matched normal saline over 10 minutes after induction of anesthesia. The primary outcome was the incidence of ED within 30 minutes after extubating. The results show an incidence of ED of 300 cases per 1,000 patients for dexmedetomidine and 500 cases per 1,000 patients for saline.",
    "zh": "一项随机对照研究调查了单剂量右美托咪定对接受七氟烷诱导麻醉的儿童出现苏醒谵妄（ED）的影响。共有2,500名年龄在2-7岁之间，计划进行扁桃体切除术的患者参与了该研究；80%的患者被随机分配接受右美托咪定0.5 mcg/kg或体积匹配的生理盐水，在麻醉诱导后10分钟内静脉注射。主要结局指标是在拔管后30分钟内ED的发生率。结果显示，右美托咪定组ED发生率为每1,000名患者中有300例，生理盐水组为每1,000名患者中有500例。"
  },
  "question": {
    "en": "Which of the following is the best estimate of the absolute risk reduction for ED following dexmedetomidine compared to saline?",
    "zh": "以下哪一项是右美托咪定与生理盐水相比，对ED的绝对风险降低的最佳估计值？"
  },
  "options": {
    "A": {
      "en": "0.80 × 2,500",
      "zh": "0.80 × 2,500"
    },
    "B": {
      "en": "(500 / 1,000) – (300 / 1,000)",
      "zh": "(500 / 1,000) – (300 / 1,000)"
    },
    "C": {
      "en": "(300 / 1,000) / (500 / 1,000)",
      "zh": "(300 / 1,000) / (500 / 1,000)"
    },
    "D": {
      "en": "1 / [(500 / 1,000) – (300 / 1,000)]",
      "zh": "1 / [(500 / 1,000) – (300 / 1,000)]"
    },
    "E": {
      "en": "[(500 / 1,000) – (300 / 1,000)] / (500 / 1,000)",
      "zh": "[(500 / 1,000) – (300 / 1,000)] / (500 / 1,000)"
    }
  },
  "correct_answer": "B",
  "explanation": {
    "en": "This randomized controlled study compared the incidence of emergence delirium (ED) in children who underwent tonsillectomy while under anesthesia induced with sevoflurane. Participants were randomized to receive dexmedetomidine 0.5 mcg/kg (ie, treatment group) or volume-matched normal saline (ie, control group) over 10 minutes after induction of anesthesia. A total of 2,500 patients were enrolled in the study, but only 2,000 (= 0.80 × 2,500) were randomized into treatments (Choice A). The incidence of ED was as follows:\n\n•\tDexmedetomidine (treatment group): 300 cases per 1,000 patients (or 300 / 1,000)\n•\tSaline (control group): 500 cases per 1,000 patients (or 500 / 1,000)\n\nThese results indicate that the absolute risk reduction (ARR) (ie, control rate – treatment rate) in ED between groups is (500 / 1,000) – (300 / 1,000) = 0.20. ARR = 0.20 indicates that 20% of patients did not develop ED as a result of having received dexmedetomidine rather than saline.\n\n(Choice C) The calculation (300 / 1,000) / (500 / 1,000) = 0.60 provides the relative risk (RR) (ie, treatment rate / control rate). RR = 0.60 indicates that the risk of ED in the dexmedetomidine group is 0.60 the risk of ED in the saline group.\n\n(Choice D) The calculation 1 / [(500 / 1,000) – (300 / 1,000)] = 5 provides the number needed to treat (NNT) (ie, 1 / ARR). NNT = 5 indicates that 5 of the patients undergoing tonsillectomy had to be given dexmedetomidine 0.5 mcg/kg over 10 minutes after induction of anesthesia with sevoflurane to avoid 1 case of ED (compared to saline).\n\n(Choice E) The calculation [(500 / 1,000) – (300 / 1,000)] / (500 / 1,000) = 0.40 provides the relative risk reduction (RRR) (ie, ARR / control rate). RRR = 0.40 indicates that dexmedetomidine offers a 40% reduction in ED compared to saline.\n\nEducational objective:\nAbsolute risk reduction (ARR) is the difference in event rate between a control group and a treatment group (ie, the percentage of patients improved by treatment). It is calculated as:\n\nARR = control rate – treatment rate",
    "zh": "这项随机对照研究比较了接受七氟烷诱导麻醉下进行扁桃体切除术的儿童出现苏醒谵妄 (ED) 的发生率。参与者被随机分配接受0.5 mcg/kg的右美托咪定（即，治疗组）或体积匹配的生理盐水（即，对照组），在麻醉诱导后10分钟内静脉注射。共有2,500名患者参与了该研究，但只有2,000名（= 0.80 × 2,500）患者被随机分配接受治疗（选项A）。ED的发生率如下：\n\n•\t右美托咪定（治疗组）：每1,000名患者中有300例（或300 / 1,000）\n•\t生理盐水（对照组）：每1,000名患者中有500例（或500 / 1,000）\n\n这些结果表明，各组间ED的绝对风险降低（ARR）（即，对照组发生率 – 治疗组发生率）为（500 / 1,000）–（300 / 1,000）= 0.20。ARR = 0.20 表明，20%的患者在接受右美托咪定而不是生理盐水后，没有发生ED。\n\n（选项C）计算（300 / 1,000）/（500 / 1,000）= 0.60 提供了相对风险 (RR)（即，治疗组发生率/对照组发生率）。RR = 0.60 表明，右美托咪定组的ED风险是生理盐水组的ED风险的0.60倍。\n\n（选项D）计算1 / [(500 / 1,000) – (300 / 1,000)] = 5 提供了需要治疗的患者数 (NNT)（即，1 / ARR）。NNT = 5 表明，接受扁桃体切除术的患者中，需要给5名患者在七氟烷麻醉诱导后10分钟内静脉注射0.5 mcg/kg的右美托咪定，以避免1例ED（与生理盐水相比）。\n\n（选项E）计算[(500 / 1,000) – (300 / 1,000)] / (500 / 1,000) = 0.40 提供了相对风险降低 (RRR)（即，ARR / 对照组发生率）。RRR = 0.40 表明，与生理盐水相比，右美托咪定可降低40%的ED。\n\n教学目标：\n绝对风险降低 (ARR) 是对照组和治疗组之间事件发生率的差异（即，通过治疗改善的患者百分比）。计算公式为：\n\nARR = 对照组发生率 – 治疗组发生率"
  },
  "summary": {
    "en": "This question tests the knowledge of biostatistics, specifically the calculation and interpretation of absolute risk reduction (ARR) in a clinical study. Understanding the difference between treatment and control groups, and the formula for ARR is essential to answer correctly.\n\nTo solve this type of question, identify the treatment and control event rates, then apply the ARR formula: ARR = Control Event Rate - Treatment Event Rate. Ensure that the rates are expressed as a proportion of the population (e.g., per 1,000 patients).",
    "zh": "本题考察了生物统计学的知识，特别是临床研究中绝对风险降低（ARR）的计算和解释。理解治疗组和对照组之间的差异以及ARR的公式对于正确回答至关重要。\n\n要解决这类问题，需要确定治疗组和对照组的事件发生率，然后应用ARR公式：ARR = 对照组事件发生率 - 治疗组事件发生率。确保这些发生率表示为总人口的比例（例如，每1,000名患者）。"
  },
  "tags": "Biostatistics; Absolute risk reduction; Emergence delirium; Dexmedetomidine; Sevoflurane; Tonsillectomy; Clinical trial; Risk assessment; Therapeutic efficacy",
  "category": "Bio",
  "question_id": "108026",
  "has_exhibits": false,
  "exhibit_count": 0,
  "exhibit_files": [],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Bio & Statistics 23\\108026",
  "extracted_at": "2025-11-05T10:27:08.931205",
  "translated_at": "2025-11-07T15:44:10.426396",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}